J Bladé

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Bisphosphonate-related osteonecrosis of the jaws – A review

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents

Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience

Pharmacokinetics of recombinant human interleukin‐2 in advanced renal cell carcinoma patients following subcutaneous application

Chronic myelogenous leukemia in nonlymphoid blastic phase

Bisphosphonate osteonecrosis of the jaw—a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

Multiple myeloma

New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin

Delivery technologies for cancer immunotherapy

STATs in oncogenesis

Status and perspectives of claims data analyses in Germany—A systematic review

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

TNF-α targeted therapeutic approaches in patients with hematologic malignancies

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Antiresorptives and Osteonecrosis of the Jaw

Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

Human mesenchymal stem cells modulate allogeneic immune cell responses

Nonsecretory multiple myeloma

Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

Advances in biology of multiple myeloma: clinical applications

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

[Multiple myeloma: description of a series of 170 cases].

Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.

Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.

Treatment of blast crisis of chronic myelogenous leukemia with vincristine, prednisone, and cytarabine.